Professor Stefan Klaus Bohlander

Professor

In: Molecular Medicine and Pathology » Medical Science » Faculty of Medical and Health Sciences

Selected publications and creative works (Research Outputs)

Barbosa, K., Deshpande, A., Chen, B.-R., Ghosh, A., Sun, Y., Dutta, S., ... Bohlander, S. K. (2019). Acute myeloid leukemia driven by the CALM-AF10 fusion gene is dependent on BMI1. Experimental hematology, 74, 42-51.e3. 10.1016/j.exphem.2019.04.003
Hunter, F. W., Devaux, J. B. L., Meng, F., Hong, C. R., Khan, A., Tsai, P., ... Marastoni, S. (2019). Functional CRISPR and shRNA Screens Identify Involvement of Mitochondrial Electron Transport in the Activation of Evofosfamide. Molecular pharmacology, 95 (6), 638-651. 10.1124/mol.118.115196
Other University of Auckland co-authors: Francis Hunter, Jules Devaux, Peter Tsai, Cristin Print
Lipert, B., Siemens, K. N., Khan, A., Barker, H. R., Tsai, P., Ketela, T. W., ... Hunter, F. W. (2019). Functional CRISPR knockout screens for modifiers of sensitivity to trastuzumab emtansine. Paper presented at ESMO Breast Cancer, Berlin, GERMANY. 2 May - 4 May 2019. ANNALS OF ONCOLOGY. (pp. 1).
Other University of Auckland co-authors: Stephen Jamieson
Angenendt, L., Bormann, E., Pabst, C., Alla, V., Görlich D, Braun, L., ... Arteaga, M. F. (2019). The neuropeptide receptor calcitonin receptor-like (CALCRL) is a potential therapeutic target in acute myeloid leukemia. Leukemia10.1038/s41375-019-0505-x
Lange, A. P., Almeida, L. Y., Araújo Silva CL, Scheucher, P. S., Chahud, F., Krause, A., ... Rego, E. M. (2019). CCAAT/enhancer-binding protein alpha (CEBPA) gene haploinsufficiency does not alter hematopoiesis or induce leukemia in Lck-CALM/AF10 transgenic mice. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 52 (6)10.1590/1414-431X20198424
Vosberg, S., Hartmann, L., Metzeler, K. H., Konstandin, N. P., Schneider, S., Varadharajan, A., ... Bohlander, S. K. (2018). Relapse of acute myeloid leukemia after allogeneic stem cell transplantation is associated with gain of WT1 alterations and high mutation load. Haematologica, 103 (12), e581-e584. 10.3324/haematol.2018.193102
Braess, J., Amler, S., Kreuzer, K.-A., Spiekermann, K., Lindemann, H. W., Lengfelder, E., ... Biersack, H. (2018). Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia-a phase 3 study. Leukemia, 32 (12), 2558-2571. 10.1038/s41375-018-0268-9
Hornung, R., Jurinovic, V., Batcha, A. M. N., Bamopoulos, S. A., Rothenberg-Thurley, M., Amler, S., ... BohlanderSK (2018). Mediation analysis reveals common mechanisms of RUNX1 point mutations and RUNX1/RUNX1T1 fusions influencing survival of patients with acute myeloid leukemia. Scientific Reports, 8 (1).10.1038/s41598-018-29593-2